Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management

Benitez Hidalgo, Olga; Bescós Cabestre, Agustí; Juarez Giménez, Juan Carlos; Gironella Mesa, Mercedes; Bosch Albareda, Francesc; Martinez Garcia, Maria Fernanda

View

Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management, 2022 (118.5Kb)

Date

2022-05

Author

Benitez Hidalgo, Olga

Bescós Cabestre, Agustí

Juarez Giménez, Juan Carlos

Gironella Mesa, Mercedes

Bosch Albareda, Francesc

Martinez Garcia, Maria Fernanda

Show full item record

Abstract

Extended half-life FIX (EHL-FIX) concentrates have been developed with the purpose of reducing the frequency of infusions in patients with severe or moderate hemophilia B. We describe the case of a 63-year-old patient with severe hemophilia B (sHB) treated with FIX-Fc fusion protein (rFIXFc) who underwent neurosurgery.

Keywords

Anesthesia; Haemophilia B; Neurosurgery

Bibliographic citation

Benitez Hidalgo O, Martinez Garcia MF, Bescos Cabestre A, Juarez Gimenez JC, Gironella Mesa M, Bosch Albareda F. Neurosurgery in a patient with severe hemophilia B: an experience using eftrenonacog alfa as perioperative management. Clin Case Reports. 2022 May;10(5):e05848.